Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study

View ORCID ProfileMichael J Lydeamore, Cameron Zachreson, Eamon Conway, Freya M Shearer, Christopher M Baker, Joshua V Ross, Joel C Miller, James M McCaw, View ORCID ProfileNicholas Geard, View ORCID ProfileJodie McVernon, View ORCID ProfileDavid J Price
doi: https://doi.org/10.1101/2024.04.22.24305704
Michael J Lydeamore
1Department of Econometrics and Business Statistics, Monash University, Clayton, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J Lydeamore
Cameron Zachreson
2School of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eamon Conway
3Population Health and Immunity Division, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Freya M Shearer
4Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M Baker
5School of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia
6Melbourne Centre for Data Science, University of Melbourne, Melbourne, Victoria, Australia
7Centre of Excellence for Biosecurity Risk Analysis, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua V Ross
8School of Computer and Mathematical Sciences, University of Adelaide, Adelaide, South Australia, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel C Miller
9Department of Mathematical and Physical Sciences, La Trobe University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M McCaw
4Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
5School of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Geard
2School of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas Geard
Jodie McVernon
10Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
11Victorian Infectious Diseases Epidemiology Unit, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jodie McVernon
David J Price
4Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
10Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David J Price
  • For correspondence: david.price1{at}unimelb.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We developed a flexible infectious disease model framework that combines a detailed individual-based model of arrival pathways (quarantine model) and an individual-based model of the arrivals environment (community model) to inform border risk assessments. The work was motivated by Australia’s desire to safely increase international arrival volumes, which had been heavily constrained since early 2020 as a result of the COVID-19 pandemic. These analyses supported decisions on quarantine and border policy in the context of the Australian government’s national reopening plan in late 2021.

The quarantine model provides a detailed representation of transmission within quarantine and time-varying infectiousness and test sensitivity within individuals, to characterise the likelihood and infectiousness of breaches from quarantine. The community model subsequently captures the impact these infectious individuals have in the presence of varying vaccination coverage, arrival volumes, public health and social measures (PHSMs) and test-trace-isolate-quarantine system effectiveness in the Australian context.

Our results showed that high vaccination coverage would be required to safely reopen with support from ongoing PHSMs, and quarantine pathways have minimal impact on infection dynamics in the presence of existing local transmission. The modelling pipeline we present can be flexibly adapted to a range of scenarios and thus provides a useful framework for generating timely risk assessments in the event of future pandemics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Australian Government Department of Health and Ageing Office of Health Protection. Additional support was provided by the National Health and Medical Research Council of Australia through its Centres of Research Excellence (SPECTRUM, GNT1170960) and Investigator Grant Schemes (J.M. Principal Research Fellowship, GNT1117140; F.M.S. Emerging Leader Fellowship, 2021/GNT2010051).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

No new datasets are presented in this research. Code to perform the analyses is available at

https://github.com/aus-covid-modelling/NationalCabinetModelling-OctNov21

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 22, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study
Michael J Lydeamore, Cameron Zachreson, Eamon Conway, Freya M Shearer, Christopher M Baker, Joshua V Ross, Joel C Miller, James M McCaw, Nicholas Geard, Jodie McVernon, David J Price
medRxiv 2024.04.22.24305704; doi: https://doi.org/10.1101/2024.04.22.24305704
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study
Michael J Lydeamore, Cameron Zachreson, Eamon Conway, Freya M Shearer, Christopher M Baker, Joshua V Ross, Joel C Miller, James M McCaw, Nicholas Geard, Jodie McVernon, David J Price
medRxiv 2024.04.22.24305704; doi: https://doi.org/10.1101/2024.04.22.24305704

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5138)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14617)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4909)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)